HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS
Go back to HALOZYME REPORTS FIRST QUARTER 2023 FINANCIAL AND OPERATING RESULTS| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 79.84 -1.73 (2.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.57 | 52 Week High | $18.39 | |||
| Open | $79.96 | 52 Week Low | $6.96 | |||
| Day High | $80.85 | P/E | N/A | |||
| Day Low | $79.04 | EPS | $-0.58 | |||
| Volume | 288,794 | |||||
